feed,title,long_url,short_url
Benzinga,"Algorhythm's SemiCab Scores Work With $200B Client, Unlocking Expansion Potential",https://benzinga.com/markets/equities/24/10/41206114/algorhythms-semicab-scores-work-with-200b-client-unlocking-expansion-potential,https://da.gd/HrNIc
Benzinga,FDA Put Brakes On Penny Stock Kezar Life Sciences' Mid-Stage Study For Lead Development Candidate After Patient Deaths,https://benzinga.com/general/biotech/24/10/41206113/fda-put-brakes-on-penny-stock-kezar-life-sciences-mid-stage-study-for-lead-development-candidate-,https://da.gd/GB1p7m
